JPRN-UMIN000041925已完成未知
egacy Effects of PCSK9 Inhibitors on Lipid-Rich Vulnerable Coronary Plaque - Legacy Effects of PCSK9 Inhibitors
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 7
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 100years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •A pregnancy or inability to provide written informed consent, Participants had already had anti-PCSK9 antibody on admission
研究者
相似试验
已完成
4 期
Modelling the impact of PCSK9 inhibitors on lipoproteins in patients with dyslipidemiaE78.5Hyperlipidaemia, unspecifiedDRKS00011663niversitätsklinikum Freiburg30
已完成
不适用
Efficacy and safety of PCSK9 inhibitor for dyslipidemiarefractory dyslipidemiaJPRN-UMIN000023483Sekino Hospital70
招募中
不适用
Impact of PCSK9 Inhibitor on the Characteristics of Lipid-rich Coronary Plaques Assessed by Near-infrared SpectroscopyIschemic Heart DiseaseJPRN-UMIN000040318Gifu Heart Center50
招募中
不适用
Impact of anti-PCSK9 antibody Alirocumab on lipid-lowering on patient motivation to treatment for hypercholesterolemia.JPRN-UMIN000029310Minamiosaka Hospital Department of Internal Medicine10
进行中（未招募）
1 期
Effect of impact of PCSK9 inhibitor on coronary microvascular dysfunction in patients with atherosclerotic cardiovascular disease proved by myocardial ischemia and needing coronarography.atherosclerotic cardiovascular diseaseEUCTR2019-003360-45-FRniversity Hospital Grenoble66